Novartis announces collaboration with Molecular Partners to develop two DARPin therapies designed for potential use against COVID-19
Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’...
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
Johnson & Johnson announced today that it is preparing to resume recruitment in the pivotal Phase 3 ENSEMBLE trial of its investigational Janssen COVID-19...
Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists
East Lyme, Connecticut, USA: Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites...
Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test
Merck, a leading science and technology company, announced a collaboration with Mammoth Biosciences Inc., of South San Francisco, California, USA, for the development, scale-up...
FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1...
Dr.Reddy’s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India
Dr.Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, today announced that they have received approval from the DrugsControllerGeneral of...
NIH initiates phase 3 clinical trial to test immune modulators for treatment of COVID-19
The National Institutes of Health (NIH) has launched an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...




























